Prognostic value of serum albumin-creatinine ratio as a biomarker in patients treated with immune checkpoint inhibitors
Our study demonstrated that sACR could serve as an independent predictor of OS, PFS, early progression, late progression, and long-term benefit in patients treated with ICIs.
Authors
- Neyran Kertmen (ORCID: https://orcid.org/0000-0001-7654-5822)
- Taha Koray Şahin (ORCID: https://orcid.org/0000-0002-3590-0426)
- Dilara Erdoğan
- Mert Tokatlı (ORCID: https://orcid.org/0000-0003-4914-7903)
- Ömer Dızdar (ORCID: https://orcid.org/0000-0003-0911-9078)
- Mustafa Erman (ORCID: https://orcid.org/0000-0001-5884-4669)
- Sercan Aksoy (ORCID: https://orcid.org/0000-0003-4984-1049)
- Onur Baş (ORCID: https://orcid.org/0000-0002-8726-0360)
- Gözde Kavgacı (ORCID: https://orcid.org/0000-0001-6960-2024)
- Şuayib Yalçın (ORCID: https://orcid.org/0000-0001-7850-6798)
- Naciye Güdük
- Nur Evşan Boyraz
- Deniz Can Güven (ORCID: https://orcid.org/0000-0002-6924-9467)
Institutions
- Sağlık Bilimleri Üniversitesi (TR)
- Universidad CES (CO)
- Elazığ Eğitim ve Araştırma Hastanesi (TR)
- Hacettepe University (TR)
Publication Details
- Journal
- Immunotherapy
- Published
- 2025-05-24
- DOI
- https://doi.org/10.1080/1750743x.2025.2513850
- Citations
- 1
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.05